Immunohistochemical analysis revealed that tranilast treatment markedly inhibited migration of the vimentin-positive tumour cells into the host brain tissue (Fig. 6a), suggesting that tranilast suppresses sNF96.2 cell invasion in vivo. The gene discussed is VIM; the disease is neoplasm.